CLINICAL TRIALS: Treatment of HCV-infected patients with advanced kidney disease

    loading  Checking for direct PDF access through Ovid

Abstract

Antiviral treatment options for HCV-infected patients with advanced kidney disease are limited because few clinical trials have tested the efficacy of antiviral drugs in this population. Now, a phase III trial of two pan-genotypic drugs demonstrates excellent viral clearance with minimal adverse events in HCV-infected patients with advanced kidney disease.

Related Topics

    loading  Loading Related Articles